Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Peter D.O. DonhauserDirector | Anavex Life SciencesAVXL | Open-market buy | 24/06/14 | 24/06/17 | 2,835 sh | $3.64 | $10,319.4 | +130.9% |
Steffen ThomasDirector | Anavex Life SciencesAVXL | Open-market buy | 24/05/15 | 24/05/17 | 5,000 sh | $4.52 | $22,600 | No record |
Christopher U. MisslingPresident and CEO | Anavex Life SciencesAVXL | Open-market sale | 24/03/28 | 24/04/01 | 73,380 sh | $5.11 | $374,971.8 | −5.5% |
Christopher U. MisslingPresident and CEO | Anavex Life SciencesAVXL | Open-market sale | 23/06/28 | 23/06/30 | 268,000 sh | $7.98 | $2,138,640 | −20.8% |